Sponsor

Universität des Saarlandes

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Universität des Saarlandes appears in 23 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials23
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

23 shown
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLCNCT06223711 · lead sponsor · 2023-10-06
RECRUITING
Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart FailureNCT06453577 · lead sponsor · 2023-05-01
COMPLETED
Adherence to Medication in Patients With Acute Decompensated Heart FailureNCT06459115 · lead sponsor · 2023-02-01
COMPLETED
Cardiometabolic Risk Factor Management and Adherence to Antihypertensive Therapy in Patients With Severe Obesity Prior to Bariatric Surgery: a Prospective Longitudinal Cohort StudyNCT07441304 · lead sponsor · 2022-08-04
COMPLETED
A Prospective, Multicenter, Randomized, Blinded, Sham-controlled, Feasibility Study of Renal Denervation in Patients With Chronic Heart FailureNCT04947670 · lead sponsor · 2022-06-13
TERMINATED
Diagnosis of Parkinson´s Disease by Means of Submandibular Gland Needle BiopsyNCT04264273 · lead sponsor · 2020-02-07
UNKNOWN
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and StoolNCT04067440 · lead sponsor · 2019-10-01
COMPLETED
Metabolic Response to Fat and GlucoseNCT02603237 · lead sponsor · 2016-07-01
COMPLETED
Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson DiseaseNCT02784145 · lead sponsor · 2016-05-01
COMPLETED
Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)NCT04833517 · lead sponsor · 2016-01-01
UNKNOWN
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)NCT02077634 · lead sponsor · 2014-05-01
COMPLETED
Cognitive Training in Heart Failure Study (CogTrain-HF)NCT02415517 · lead sponsor · 2014-01-01
COMPLETED
Choline Metabolites in People With Prostate Cancer and Those With Benign HyperplasiaNCT06380062 · lead sponsor · 2012-01-12
COMPLETED
Prognostic Value of FP-CIT-SPECT in Parkinson´s DiseaseNCT01038310 · lead sponsor · 2010-01-01
COMPLETED
Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine MethodsNCT01003535 · lead sponsor · 2010-01-01
COMPLETED
B-Vitamins and Polyneuropathy in Patients With Type 2 DiabetesNCT02588898 · lead sponsor · 2009-09-01
COMPLETED
Cognitive Impairment in Patients With Heart FailureNCT00837889 · lead sponsor · 2009-01-01
COMPLETED
Homburg Cream & Sugar StudyNCT00628524 · lead sponsor · 2008-02-01
COMPLETED
Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart FailureNCT00934609 · lead sponsor
COMPLETED
Multimodal Preventive Trial for Alzheimer's DiseaseNCT03249688 · collaborator · 2017-10-16
COMPLETED
Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study).NCT02310061 · collaborator · 2013-03-01
COMPLETED
Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart FailureNCT01692119 · collaborator · 2012-10-01
COMPLETED
Bupropion for the Treatment of Apathy in Alzheimer's DementiaNCT01047254 · collaborator · 2010-01-01
COMPLETED

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Universität des Saarlandes as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
durvalumab1
placebo1

Sponsor roles

lead sponsor19
collaborator4
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.